Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7DTZ

FGFR4 complex with a covalent inhibitor

Summary for 7DTZ
Entry DOI10.2210/pdb7dtz/pdb
DescriptorFibroblast growth factor receptor 4, N-[2-[[5-[[2,6-bis(chloranyl)-3,5-dimethoxy-phenyl]methoxy]pyrimidin-2-yl]amino]-3-methyl-phenyl]-2-fluoranyl-prop-2-enamide, SULFATE ION, ... (4 entities in total)
Functional Keywordsinhibitor, covalent, crystal, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight35112.23
Authors
Chen, X.J.,Dai, S.Y.,Chen, Y.H. (deposition date: 2021-01-07, release date: 2021-04-14, Last modification date: 2024-10-23)
Primary citationDeng, W.,Chen, X.,Jiang, K.,Song, X.,Huang, M.,Tu, Z.C.,Zhang, Z.,Lin, X.,Ortega, R.,Patterson, A.V.,Smaill, J.B.,Ding, K.,Chen, S.,Chen, Y.,Lu, X.
Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors.
Acs Med.Chem.Lett., 12:647-652, 2021
Cited by
PubMed Abstract: Covalent kinase inhibitors are rapidly emerging as a class of therapeutics with clinical benefits. Herein we report a series of selective 2-aminopyrimidine-based fibroblast growth factor receptor 4 (FGFR4) inhibitors exploring different types of cysteine-targeting warheads. The structure-activity relationship study revealed that the chemically tuned warheads α-fluoro acrylamide, vinylsulfonamide, and acetaldehyde amine were suitable as covalent warheads for the design of selective FGFR4 inhibitors. Compounds , , and selectively suppressed FGFR4 enzymatic activity with IC values of 53 ± 18, 45 ± 11, and 16 ± 4 nM, respectively, while sparing FGFR1/2/3. X-ray crystal structure and MALDI-TOF studies demonstrated that compound bearing the α-fluoro acrylamide binds to FGFR4 with an irreversible binding mode, whereas compound with an acetaldehyde amine binds to FGFR4 with a reversible covalent mode. and might provide some fundamental structural information for the rational design of new selective FGFR4 inhibitors.
PubMed: 33859803
DOI: 10.1021/acsmedchemlett.1c00052
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.01 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon